本頁面由Tiger Trade Technology Pte. Ltd.提供服務

XORTX Therapeutics Inc.

0.3900
0.0000
盤後0.39000.00000.00%16:00 EST
成交量:3.71萬
成交額:1.45萬
市值:271.53萬
市盈率:-0.79
高:0.4010
開:0.3820
低:0.3820
收:0.3900
52周最高:1.41
52周最低:0.3819
股本:696.22萬
流通股本:625.34萬
量比:0.35
換手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-0.4961
每股收益(LYR):-1.1511
淨資產收益率:-94.63%
總資產收益率:-45.32%
市淨率:1.38
市盈率(LYR):-0.34

資料載入中...

2026/02/13

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/05/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2023/01/27

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/21

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/09/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/12

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers